US 12239712
Combination therapy for the treatment of liver disease
granted A61KA61K31/192A61K31/198
Quick answer
US patent 12239712 (Combination therapy for the treatment of liver disease) held by GALMED RESEARCH AND DEVELOPMENT LTD expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GALMED RESEARCH AND DEVELOPMENT LTD
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/192, A61K31/198, A61K31/53, A61K31/575